More Glenmark Pharmaceuticals Limited news
Press Release Nov 18 2025
Nov 18, 2025 at 2:40 PM EST · Issued by Glenmark Pharmaceuticals Limited
Filed with NSE · Nov 18, 2025 at 2:40 PM EST · 3 pages · English
Release Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated November 18, 2025, titled "Cosmo and Glenmark Announce Market Authorization of Winlevi® (clascoterone) 10 mg/g cream for Treatment of Acne in 15 countries in Europe ".
Glenmark Pharmaceuticals Limited on 6ix
Earlier from Glenmark Pharmaceuticals Press Release Nov 14 2025 Nov 14, 2025 Press Release Nov 10 2025 Nov 10, 2025 Press Release Nov 04 2025 Nov 4, 2025 Glenmark Pharmaceuticals Inc., USA to launch 8.4% Sodium Bicarbonate Injection USP, 50 mEq/50 mL (1 mEq/mL) Single-Dose Vial Nov 4, 2025 Glenmark Pharmaceuticals Inc., USA to launch Ropivacaine Hydrochloride Injection USP, 40 mg/20 mL (2mg/mL), 150 mg/30 mL (5 mg/mL), and 200 mg/20 mL (10 mg/mL) Single-Dose Vials Oct 24, 2025 Later from Glenmark Pharmaceuticals All Glenmark Pharmaceuticals news releases↗
